Tri Chemical Laboratories Inc.JP:4369

Market cap
¥84.4B
P/E ratio
17.6x
2012/012013/012014/012015/012016/012017/012018/012019/012020/012021/012022/012023/012024/012025/01
Revenue4,0023,2183,3624,1034,9575,4706,4467,7928,2679,80111,57413,80311,24618,905
Revenue growth (%)-
Cost of revenue---2,6713,0463,2973,5594,2004,3155,4216,7398,2247,16010,894
Gross profit---1,4321,9102,1732,8873,5923,9534,3814,8355,5794,0868,012
Gross margin (%)---
Operating margin (%)---
Operating income ---3517229771,5982,1532,3272,6912,9763,5041,9475,256
Operating expenses ---1,0811,1891,1961,2891,4391,6261,6901,8592,0752,1382,756
Income before tax 29061534266949751,6232,9323,7444,3235,2946,1863,2766,583
Pretax margin (%)7.21.91.610.41417.825.237.645.344.145.744.829.134.8
Provision for income taxes---2162203514796648049461,2001,3548061,621
Effective tax rate (%)---
Net income 17516683614737671,1462,2672,9403,3774,0954,8322,4714,331
Net income margin (%)
Earnings per share24.672.189.449.4561.7798.3146.65290.23376.33108.08126.33148.776.03152.69
Diluted EPS23.512.189.3948.0160.8898.3146.65290.23376.33108.08126.33148.776.03152.69
Dividend payout ratio (%)-
Dividend per share5-2710162145586820303035
EBITDA---
EBITDA margin (%)---